Prot #GS-US-384-1497: A Phase 2, Randomized, Open Label Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 alone or in Combination with Simtuzumab (SIM) in Subjects with Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Project: Research project

Project Details

StatusFinished
Effective start/end date8/11/158/11/18

Funding

  • PPD Development (Prot #GS-US-384-1497)
  • Gilead Sciences, Inc. (Prot #GS-US-384-1497)